This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.
|Number of pages||9|
|Publication status||Published - Mar 2004|
- rheumatoid arthritis
- anti-TNF therapy